CAS Printout for In 173570, Apr. 1996.* |
CAS Printout for Schmidhalter et al., Nov. 1990.* |
CAS Printout for Begue et al., Dec. 1969.* |
Van Dijk, Jeanette P.M. et al., “Nicotine inhibits cytokine synthesis by mouse colonic mucosa,” European Journal of Pharmacology, 278, R11-R12 (1995). |
Hanisch, Uwe-Karsten et al., “Modulation of Hippocampal Acetylcholine Release: A Potent Central Action of Interleukin-2,” The Journal of Neuroscience, vol. 13 (8), pp. 3368-3374 (1993). |
Madretsma, Stanley et al., “In-vivo effect of nicotine on cytokine production by human non-adherent mononuclear cells,” European Journal of Gastroenterology & Hepatology, vol. 8, No. 10, pp. 1017-1020 (1996). |
Madretsma, G.S., et al., “Nicotine inhibits the in vitro production of interleukin 2 and tumour necrosis factor-α by human monocuclear cells,” Immunopharmacology, 35, pp. 47-51 (1996). |
Peacock, Mark E. et al., “The Effect of Nicotine on Reproduction and Attachment of Human Gingival Fibroblasts in vitro,” J. Periodontal, vol. 64, No. 7, pp. 658-665 (1993). |
Sandborn, W. J. et al., “Nicotine tartrate liquid enemas for mildly to moderately active left-sided ulcerative colitis unresponsive to first-line therapy: a pilot study,” Ailment Pharmacol. Ther., 11, pp. 663-671 (1997). |
Zijlstra, F. J. et al., “Effect of nicotine on rectal mucus and mucosal eicosanoids,” Gut, 35, pp. 247-251 (1994). |
Pullan, Rupert D., “Colonic mucus, smoking and ulcerative colitis,” Ann R. Coll. Surg Engl., 78, pp. 85-91 (1996). |
Pullan, Robert D. et al., “Transdermal Nicotine for Active Ulcerative Colitis,” The New England Journal of Medicine, vol. 330, No. 12, pp. 811-815 (1994). |
Silverstein, Marc D., M.D. et al., “Cigarette Smoking and Ulcerative Colitis: A Case-Control Study”, Mayo Clin. Proc., vol. 69. pp. 425-429 (1994). |
Birtwistle, Jon, Postgrad Med. J., “The role of cigarettes and nicotine in the onset and treatment of ulcerative colitis,” vol. 72, pp. 714-718 (1996). |
Ebadi, M. et al., “Neurotrophins And Their Receptors in Nerve Injury and Repair,” Neurochem Int., vol. 30, Nos. 4/5, pp. 347-374 (1997). |
Matthys, Patrick Ph.D. et al., “Cytokines and Cachexia,” Nutrition, vol. 13, No. 9, pp. 763-770 (1997). |
Jonakait, G. Miller, TINS, “Neural-immune interactions in sympathetic ganglia,” vol. 16, No. 10, pp. 419-423 (1993). |
Wallace, John L. et al., “Inflammatory Mediators in Gastrointestinal Defense and Injury,” Proc. Soc. Exp. Biol. Med., vol. 214, pp. 192-203 (1997). |
Barnes, Peter J., Int. “Nuclear Factor-χ-B,” J. Biochem. Cell Biol., vol. 29, No. 6, pp. 867-870 (1997). |
Sartor, R. Balfour M.D., “Pathogenesis and Immune Mechanisms of Chronic Inflammatory Bowel Diseases,” The American Journal of Gastroenterology, vol. 92, No. 12, pp. 5S-11S (1997). |
International Search Report, PCT/US99/19906, Jan. 13, 2000. |
Holladay, M. W. et al., J. Med. Chem., vol. 40, No. 26, pp. 4169-4194 (1997). |
Olesen, P. H. et al., Bioorganic & Medicinal Chemistry Letters, vol. 7, No. 15, pp. 1963-1968 (1997). |
Yanina et al, Khim.-Karm, vol. 21(7), pp. 808-811 (1987). |